desogestrel has been researched along with Cardiovascular Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amies Oelschlager, AM; Debiec, KE; Mantrala, MD; Micks, EA; Nizamic, T; Prager, SW | 1 |
| Goel, N; Priya, K; Rajaram, S | 1 |
| Kaplan, PF; Meendering, JR; Miller, NP; Minson, CT; Torgrimson, BN | 1 |
| Debski, R; Kotarski, J; Paszkowski, T; Pawelczyk, L; Skrzypulec, V; Tomaszewski, J | 1 |
| Weisberg, E | 1 |
| Imthurn, B; Merki-Feld, GS; Rosselli, M; Spanaus, K | 2 |
| Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R | 1 |
| Döring, A; Fröhlich, M; Koenig, W; Löwel, H | 1 |
| Durrington, PN; Kwok, S; Laing, I; Mackness, B; Mackness, MI; McElduff, P; Morgan, J; Prais, H; Sci, FM; Selby, PL; Yates, AP | 1 |
| Anderson, S; Durrington, PN; Gibson, MJ; Heald, A; Kaushal, K; Redpath, M; Selby, PL | 1 |
| Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Sobel, NB | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Bergman, U; Daling, J; Grimes, D; Mills, A; Palmer, JR; Rosenberg, L; Sands, MI | 1 |
| Berg, G; Brenner, H; Kohlmeier, L | 1 |
| Hicks Gómez, JJ; Téllez Martínez, J; Vázquez Hernández, L | 1 |
| Colau, JC | 1 |
| Bak, AA; Bots, ML; Coelingh Bennink, HJ; de Kleijn, MJ; Grobbee, DE; Hofman, A; Planellas, J; Westendorp, IC; Witteman, JC | 1 |
| Boers, GH; Eskes, TK; Steegers, EA; Steegers-Theunissen, RP; Thomas, CM; Trijbels, FJ | 1 |
| Hoppe, G | 1 |
| Fotherby, K | 1 |
5 review(s) available for desogestrel and Cardiovascular Diseases
| Article | Year |
|---|---|
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Modern oral contraceptives and cardiovascular disease.
Topics: Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Myocardial Infarction; Norpregnenes; Risk Factors; Thromboembolism; United States; United States Department of Agriculture; World Health Organization | 1997 |
[Clinical and metabolic effects of oral contraceptives].
Topics: Adipose Tissue; Adult; Age Factors; Biliary Tract; Blood Coagulation Factors; Blood Pressure; Carbohydrate Metabolism; Cardiovascular Diseases; Cardiovascular System; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Genitalia, Female; Hemorrhage; Humans; Lipoproteins; Liver; Progesterone Congeners; Progestins; Risk Factors; Skin; Thrombosis | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Oral contraceptives, lipids and cardiovascular disease.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking | 1985 |
6 trial(s) available for desogestrel and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
Implanon use lowers plasma concentrations of high-molecular-weight adiponectin.
Topics: Adiponectin; Adult; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Desogestrel; Female; Humans; Longitudinal Studies; Molecular Weight; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Testosterone | 2011 |
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Topics: Aryldialkylphosphatase; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Desogestrel; Drug Administration Schedule; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Insulin; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors; Statistics, Nonparametric; Triglycerides | 2004 |
Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Topics: Blood Glucose; Cardiovascular Diseases; Desogestrel; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors | 2005 |
The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial.
Topics: Adult; Cardiovascular Diseases; Carotid Artery, Common; Compliance; Confidence Intervals; Desogestrel; Double-Blind Method; Elasticity; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Probability; Reference Values; Treatment Outcome; Ultrasonography; Vascular Patency | 2000 |
Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study.
Topics: Adult; Cardiovascular Diseases; Causality; Contraceptives, Oral; Desogestrel; Fasting; Female; Homocysteine; Humans; Norpregnenes; Pyridoxal Phosphate; Vitamin B 12 | 1992 |
13 other study(ies) available for desogestrel and Cardiovascular Diseases
| Article | Year |
|---|---|
Long acting reversible contraception in adolescents with cardiovascular conditions.
Topics: Adolescent; Cardiovascular Diseases; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Young Adult | 2014 |
Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.
Topics: Adolescent; Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Risk Factors; Vasodilation; Young Adult | 2009 |
[The statement of Polish Gynecological Society experts on oral use of contraceptive 75 microg desogestrel minipill in different clinical cases--state of art in 2008].
Topics: Age Factors; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Inservice Training; National Health Programs; Poland; Progestins; Quality Assurance, Health Care; Risk Factors; Societies, Medical; Women's Health; Women's Health Services | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
No effect of Implanon® on inflammatory cardiovascular parameters.
Topics: Adiponectin; Adolescent; Adult; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Contraceptive Agents, Female; Desogestrel; Female; Humans; Interleukin-6; Lipoprotein(a); Progesterone Congeners; Prospective Studies; Young Adult | 2011 |
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors | 2013 |
Third generation oral contraceptive use and cardiovascular risk factors.
Topics: Adult; Blood Viscosity; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Fibrinogen; Humans; Norpregnenes; Risk Factors; Smoking | 2004 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
Effect of oral contraceptive progestins on serum copper concentration.
Topics: Adolescent; Adult; Androgen Antagonists; Cardiovascular Diseases; Contraceptives, Oral; Copper; Cross-Sectional Studies; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Progestins; Surveys and Questionnaires | 1998 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |